Title:
SODIUM SALT OF HCV NS3 PROTEASE INHIBITOR
Document Type and Number:
WIPO Patent Application WO/2016/019845
Kind Code:
A1
Abstract:
Disclosed are a sodium salt of HCV NS3 protease inhibitor, preparation method therefor, pharmaceutical compositions thereof, and use thereof in preventing or treating the infection of Hepatitis C Virus (HCV). Compared with other salts, the sodium salt of HCV NS3 protease inhibitor of the present invention has better fluidity, higher stability and better pharmacokinetic parameters.
Inventors:
YANG LING (CN)
GU HONGMEI (CN)
LIU FEI (CN)
CHEN ZHILIN (CN)
TIAN XIN (CN)
PENG YAN (CN)
ZHU JINLEI (CN)
LV PENG (CN)
GU HONGMEI (CN)
LIU FEI (CN)
CHEN ZHILIN (CN)
TIAN XIN (CN)
PENG YAN (CN)
ZHU JINLEI (CN)
LV PENG (CN)
Application Number:
PCT/CN2015/086017
Publication Date:
February 11, 2016
Filing Date:
August 04, 2015
Export Citation:
Assignee:
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD (CN)
International Classes:
C07D403/12; A61K31/4035; A61P31/14
Domestic Patent References:
| WO2012176149A1 | 2012-12-27 |
Foreign References:
| CN103328466A | 2013-09-25 | |||
| CN102140100A | 2011-08-03 |
Attorney, Agent or Firm:
BEIJING SANYOU INTELLECTUAL PROPERTY AGENCY LTD. (CN)
北京三友知识产权代理有限公司 (CN)
北京三友知识产权代理有限公司 (CN)
Download PDF: